Skip to content
10-Q

Quarterly Report

Comera Life Sciences Holdings, Inc.

0000950170-23-062130

← back to feed
Filed
Nov 9, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2023 · Nov 8, 2023 30.74M sh
Shares Diluted Q3 2023 · Sep 30, 2023 23.11M sh
Shares Diluted Q3 2023 · Sep 30, 2023 20.45M sh
Shares Diluted Q3 2023 · Sep 30, 2022 16.02M sh
Shares Diluted Q3 2023 · Sep 30, 2022 8.29M sh
Capex Q3 2023 · Sep 30, 2023 $94.01K
Capex Q3 2023 · Sep 30, 2022 $28.61K
Operating Cash Flow Q3 2023 · Sep 30, 2023 −$4.81M
Operating Cash Flow Q3 2023 · Sep 30, 2022 −$7.92M
Short Term Debt Q3 2023 · Sep 30, 2023 $389.87K
Short Term Debt Q3 2023 · Dec 31, 2022 $455.56K
Cash And Equivalents Q3 2023 · Sep 30, 2023 $1.77M
Cash And Equivalents Q3 2023 · Dec 31, 2022 $446.61K
Cash And Equivalents Q3 2023 · Sep 30, 2022 $2.67M
Stockholders Equity Q3 2023 · Sep 30, 2023 −$4.22M
Stockholders Equity Q3 2023 · Jun 30, 2023 −$6.35M
Stockholders Equity Q3 2023 · Mar 31, 2023 −$5.26M
Stockholders Equity Q3 2023 · Dec 31, 2022 −$6.25M
Stockholders Equity Q3 2023 · Sep 30, 2022 −$3.43M
Stockholders Equity Q3 2023 · Jun 30, 2022 −$1.79M
Stockholders Equity Q3 2023 · Mar 31, 2022 −$17.09M
Stockholders Equity Q3 2023 · Dec 31, 2021 −$14.69M
Current Liabilities Q3 2023 · Sep 30, 2023 $2.93M
Current Liabilities Q3 2023 · Dec 31, 2022 $5.06M
Total Liabilities Q3 2023 · Sep 30, 2023 $2.97M
Total Liabilities Q3 2023 · Dec 31, 2022 $5.46M
Current Assets Q3 2023 · Sep 30, 2023 $2.63M
Current Assets Q3 2023 · Dec 31, 2022 $3.06M
Total Assets Q3 2023 · Sep 30, 2023 $3.07M
Total Assets Q3 2023 · Dec 31, 2022 $3.73M
Eps Diluted Q3 2023 · Sep 30, 2023 −$0.10
Eps Diluted Q3 2023 · Sep 30, 2023 −$0.31
Eps Diluted Q3 2023 · Sep 30, 2022 −$0.20
Eps Diluted Q3 2023 · Sep 30, 2022 −$1.85
Eps Basic Q3 2023 · Sep 30, 2023 −$0.10
Eps Basic Q3 2023 · Sep 30, 2023 −$0.31
Eps Basic Q3 2023 · Sep 30, 2022 −$0.20
Eps Basic Q3 2023 · Sep 30, 2022 −$1.85
Sga Expense Q3 2023 · Sep 30, 2023 $1.89M
Sga Expense Q3 2023 · Sep 30, 2023 $5.82M
Sga Expense Q3 2023 · Sep 30, 2022 $2.31M
Sga Expense Q3 2023 · Sep 30, 2022 $8.03M
Rd Expense Q3 2023 · Sep 30, 2023 $366.02K
Rd Expense Q3 2023 · Sep 30, 2023 $945.42K
Rd Expense Q3 2023 · Sep 30, 2022 $394.8K
Rd Expense Q3 2023 · Sep 30, 2022 $1.25M
Net Income Q3 2023 · Sep 30, 2023 −$2.15M
Net Income Q3 2023 · Sep 30, 2023 −$6.05M
Net Income Q3 2023 · Jun 30, 2023 −$1.41M
Net Income Q3 2023 · Mar 31, 2023 −$2.48M
Net Income Q3 2023 · Sep 30, 2022 −$3.08M
Net Income Q3 2023 · Sep 30, 2022 −$15.04M
Net Income Q3 2023 · Jun 30, 2022 −$9.09M
Net Income Q3 2023 · Mar 31, 2022 −$2.88M
Operating Income Q3 2023 · Sep 30, 2023 −$2.16M
Operating Income Q3 2023 · Sep 30, 2023 −$6.14M
Operating Income Q3 2023 · Sep 30, 2022 −$2.54M
Operating Income Q3 2023 · Sep 30, 2022 −$8.96M
Cost Of Revenue Q3 2023 · Sep 30, 2023 $41.96K
Cost Of Revenue Q3 2023 · Sep 30, 2023 $214.52K
Cost Of Revenue Q3 2023 · Sep 30, 2022 $60.96K
Cost Of Revenue Q3 2023 · Sep 30, 2022 $160.03K
Revenue Q3 2023 · Sep 30, 2023 $136.31K
Revenue Q3 2023 · Sep 30, 2023 $844.28K
Revenue Q3 2023 · Sep 30, 2022 $234.92K
Revenue Q3 2023 · Sep 30, 2022 $476.98K